A Chinese investor consortium is buying a majority stake in Australian vitamin company Nature’s Care, in a deal that a source said values the firm at about A$800 million ($619.92 million).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in